US FDA approves Regeneron's drug for generalized myasthenia gravis
REGN•The US FDA approved Regeneron Pharmaceuticals' drug to treat adults with generalized myasthenia gravis who test positive for anti-acetylcholine receptor antibodies.
1. FDA approval
The US Food and Drug Administration approved Regeneron Pharmaceuticals' drug for adults with generalized myasthenia gravis who test positive for anti-acetylcholine receptor antibodies, the company said Wednesday.




